Showing results (1991-2000 of 2,238) with videos related to
Sort By:
Pageof 224
Journal of Cataract and Refractive Surgery|January 13, 2026
Primary calcification of hydrophilic acrylic lenses in a large population: incidence and the outcomes of lens exchange proceduresDimitris Kazakos, Jan A Venter, Stephen J Hannan, et al.Plos One|December 9, 2014
Soilless plant growth media influence the efficacy of phytohormones and phytohormone inhibitorsNorman B Best, Thomas Hartwig, Joshua S Budka, et al.Surgical Infections|February 10, 2016
Comparing Readmissions and Infectious Complications of Blunt Splenic Injuries Using a Statewide DatabaseOlubode A Olufajo, Arturo Rios-Diaz, Allan B Peetz, et al.Plos One|February 19, 2020
Timing is everything: Early do-not-resuscitate orders in the intensive care unit and patient outcomesDaniel J Ouyang, Lindsay Lief, David Russell, et al.Investigational New Drugs|January 1, 1986
Recombinant gamma interferon in advanced breast cancer: a phase II trialH B Muss, M Caponera, P J Zekan, et al.The Journal of Infectious Diseases|December 1, 1996
After AIDS clinical trial 076: the changing pattern of zidovudine use during pregnancy, and the subsequent reduction in the vertical transmission of human immunodeficiency virus in a cohort of infected women and their infants. Women and Infants Transmission Study GroupE R Cooper, R P Nugent, C Diaz, et al.Proceedings of the National Academy of Sciences of the United States of America|February 6, 2010
Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progressionAnne Le, Charles R Cooper, Arvin M Gouw, et al.Elementa (Washington, D.C.)|October 27, 2018
Scientific assessment of background ozone over the U.S.: Implications for air quality managementDaniel A Jaff, Owen R Cooper, Arlene M Fiore, et al.Geohealth|March 26, 2025
Evaluating Heat Risk: Comparing On-Site WBGT Measurements Versus Smartphone Application EstimatesA J Grundstein, S W Yeargin, E R Cooper, et al.Seminars in Oncology|March 1, 1985
Megestrol acetate v tamoxifen in advanced breast cancer: a phase III trial of the Piedmont Oncology Association (POA)H B Muss, E H Paschold, W R Black, et al.Pageof 224